Farms.com Home   News

Pulse Markets Quiet

Prairie pulse markets are quiet, amid cautious buyers and reluctant sellers.

“We are in a situation where we have to wait and see,” said Marcos Mosnaim of Mercais Commodities in Toronto. “The market is super quiet right now. At these prices, interest from buyers to take positions is small (and) interest from growers is small as well.”

That has especially been the case for lentils and peas, Mosnaim added.

Prairie pulse prices shot sharply higher about a month ago but have since levelled off and held steady since then. For example, some Green lentil prices jumped as much as 8 cents/lb but have largely flatlined over the past week. Depending on size, Greens are now fetching between 42.5 and 66 cents/lb.

Mosnaim said there has not been much going on the pulse market for about the last three weeks, as buyers simply haven’t been eager to acquire a great deal of product. Conversely, farmers can store pulses in their bins for an extended period, waiting for prices to move higher.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.